Listed since August 2026
Schazoo Pharmaceutical Laboratories (Pvt) Ltd. is a Pakistan-based pharmaceutical manufacturing company with a long history in the healthcare industry. The company was founded in 1951 and has developed into a pharmaceutical organization involved in the development, manufacturing and marketing of healthcare products for national and international markets.
The corporate head office of Schazoo Pharmaceutical Laboratories is located at 71-B, C/2, Liberty Market, Gulberg III, Lahore, Pakistan. The company lists its corporate office telephone number as +92 42 35760882-4. The head office supports the company's corporate, business development, export, marketing and administrative activities.
Schazoo operates in the pharmaceutical manufacturing sector and produces a range of branded generic and unique healthcare products. Its manufacturing activities cover multiple dosage forms and therapeutic categories. The company states that its products are manufactured under quality-control systems and according to applicable local and international regulatory standards.
Schazoo Pharmaceutical Laboratories traces its origins to 1951. Over the decades, the company has developed manufacturing capabilities and expanded its business into international markets. The company describes its history as more than half a century of work in healthcare, including product development, manufacturing and marketing.
The company's current manufacturing plant was inaugurated in 2009. According to Schazoo, the purpose-built manufacturing facility was designed with consideration for international pharmaceutical manufacturing requirements and standards. The manufacturing plant is located at Kalalwala Stop, 20 km Lahore-Jaranwala Road, District Sheikhupura, Pakistan.
Quality assurance is an important part of Schazoo's pharmaceutical operations. The company states that its manufacturing facility operates with a quality management system and controlled personnel and material flows. Its stated quality policy focuses on providing pharmaceutical products according to international and local regulatory standards.
Schazoo maintains a research and development function for new product development and design. The company states that its R&D activities follow defined procedures and standard operating procedures for the development of pharmaceutical products.
The company also maintains quality-control and microbiological testing functions. According to its official information, Schazoo products undergo testing and approval through its quality-control and microbiological testing departments. These activities support the company's pharmaceutical manufacturing and product-quality objectives.
Schazoo's manufacturing portfolio includes several pharmaceutical dosage forms. The company's official website identifies tablets, capsules, syrups, dry powders, suspensions, eye drops, nasal sprays and injectables among its manufacturing capabilities.
Schazoo has an international business and export orientation. The company states that its products are marketed and exported to countries in Asia and Africa, with products also undergoing registration processes in additional international markets.
Schazoo states that its manufacturing facility is designed to comply with standards and requirements associated with organizations and regulatory authorities including WHO, USFDA, Health Canada, EMEA, MHRA-UK, Singapore and UAE requirements. These statements describe the company's manufacturing design and quality objectives; specific product registrations or approvals should be verified separately for each product and market.
The company's current website identifies ISO 9001:2015 Quality Management Systems and ISO 14001:2015 Environmental Management Systems in its corporate information.
The Lahore head office supports corporate operations and business development activities. Schazoo also maintains dedicated functions for exports and international marketing, reflecting its focus on supplying pharmaceutical products to markets outside Pakistan.
Company: Schazoo Pharmaceutical Laboratories (Pvt) Ltd.
Head Office: 71-B, C/2, Liberty Market, Gulberg III, Lahore, Pakistan
Phone: +92 42 35760882-4
Industry: Pharmaceutical Manufacturing
Founded: 1951
Manufacturing Plant: Kalalwala Stop, 20 km Lahore-Jaranwala Road, District Sheikhupura, Pakistan.
Schazoo Pharmaceutical Laboratories (Pvt) Ltd. is an established Pakistani pharmaceutical manufacturer founded in 1951. Its operations include pharmaceutical product development, manufacturing, quality control, research and development, marketing and international exports. The company's Lahore corporate office is located in Gulberg III, while its main manufacturing facility is located on Lahore-Jaranwala Road in District Sheikhupura.
Schazoo Pharmaceutical Laboratories manufactures branded generic and unique pharmaceutical products for healthcare markets. Its manufacturing operations cover multiple therapeutic categories and dosage forms, supported by quality-control and pharmaceutical manufacturing systems.
The company manufactures solid oral dosage forms including tablets and capsules. These products are manufactured within the company's pharmaceutical production facilities under established manufacturing and quality-control procedures.
Schazoo has liquid pharmaceutical manufacturing capabilities, including oral syrups and suspensions. These dosage forms are used across different therapeutic categories and are part of the company's established production capabilities.
Injectable pharmaceutical products are included among Schazoo's manufacturing capabilities. Regulatory documentation from the Drug Regulatory Authority of Pakistan has also identified injectable manufacturing sections at the company's Sheikhupura manufacturing facility.
Schazoo manufactures ophthalmological products, including eye drops. Its current product catalogue identifies ophthalmologicals as one of its product categories and lists multiple products within this area.
Nasal sprays are another dosage form included in the company's manufacturing portfolio. Schazoo's official product information identifies nasal sprays as a dedicated category.
The company manufactures dry powder pharmaceutical preparations, including dry powder suspensions. These products form part of Schazoo's broader oral pharmaceutical manufacturing capabilities.
Schazoo's product catalogue includes an Analgesics category. These products are associated with pain-management and related therapeutic applications.
The company's product portfolio includes antibiotics and anti-infective medicines. The current catalogue identifies antibiotics as a product category, while company materials also describe anti-infectives among its therapeutic areas.
Schazoo lists Anthelmintics among its pharmaceutical categories. These medicines are used in the management of certain parasitic worm infections.
Anti-malarial medicines are also included in the company's current product categories. The company identifies anti-malarials as one of its areas of pharmaceutical production.
The product catalogue includes anti-histamines as well as cough and cold preparations. These products form part of the company's respiratory and allergy-related pharmaceutical portfolio.
Schazoo's portfolio includes drugs acting on the gastrointestinal system as well as products for gastric ulcer and hyperacidity. These categories are listed in the company's current product catalogue.
The company manufactures multivitamins, minerals and calcium with vitamin D preparations. These products form part of its nutritional and supplementation-related pharmaceutical categories.
Dermatological products are included in the company's catalogue under the Derma category. These products are intended for skin-related therapeutic applications.
Schazoo's product categories include anti-convulsants, anti-epileptic and psychotropic medicines, as well as anxiolytics, antidepressants and antipsychotics. These categories cover a range of neurological and psychiatric therapeutic applications.
The company's product catalogue contains a significant ophthalmological category, alongside specialized therapeutic areas such as psychostimulants and nootropics, immune-mediated inflammatory products and non-steroidal aromatase inhibitors.
Schazoo maintains an R&D department focused on new product development and product design. Its development work follows established procedures and standard operating procedures intended to support pharmaceutical product development.
Quality-control and microbiological testing are integrated into the company's manufacturing operations. Schazoo states that its products are thoroughly tested and approved through its quality-control and microbiological testing departments.
Schazoo provides international marketing and export activities for its pharmaceutical products. The company states that it exports and markets products in several Asian and African countries and continues to pursue registration in additional international markets.
Product development is supported by the company's research and technical operations. Its manufacturing portfolio includes multiple pharmaceutical dosage forms and therapeutic categories, allowing the company to develop and manufacture products for different healthcare requirements.
Schazoo's official product catalogue contains individual product listings under its therapeutic categories. The availability, registration status and market authorization of any particular medicine can vary by country and product. Medicines should be used only according to appropriate medical or pharmaceutical guidance.
Schazoo Pharmaceutical Laboratories offers pharmaceutical manufacturing, product development, research and development, quality-control, microbiological testing, export and international marketing services. Its product portfolio covers analgesics, antibiotics, anti-malarials, anthelmintics, gastrointestinal medicines, vitamins and minerals, dermatological products, ophthalmologicals, neurological and psychiatric medicines and several other therapeutic categories.